Photo from wikipedia
Crizotinib is an anaplastic lymphoma kinase (ALK) inhibitor that was approved for ALK-harboring lung cancer. There have been reports about the development and progression of renal cysts from crizotinib. We… Click to show full abstract
Crizotinib is an anaplastic lymphoma kinase (ALK) inhibitor that was approved for ALK-harboring lung cancer. There have been reports about the development and progression of renal cysts from crizotinib. We report a series of 3 cases of crizotinib-associated renal cysts in patients admitted to our institution, with different kinds of presentation. A monitor for complex renal cysts is warranted in patients receiving crizotinib.
Keywords:
lymphoma kinase;
associated renal;
crizotinib associated;
anaplastic lymphoma;
renal cysts;
lung cancer
Journal Title: Urologia Internationalis
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Urologia Internationalis
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!